Atherosclerosis progression was more than twice as common in younger people with systemic lupus erythematosus (SLE) than in ...

Scientists at the Oklahoma Medical Research Foundation are one step closer to determining the genetic trigger for lupus in ...

A new study explored the potential of IncRNA CASC2 and miR-155 levels as non-invasive diagnostic biomarkers for systemic lupus erythematosus (SLE) and lupus nephritis (LN). Previous studies have found ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Cori Broadus shares her journey through a recent stroke and recovery, revealing the dangers of stopping medication cold turkey.

Legendary R&B singer Eddie Levert is mourning the loss of his daughter, Ryan Levert. The O’Jays singer’s grandchildren, ...

Felzartamab is under clinical development by Biogen and currently in Phase I for Lupus Nephritis. According to GlobalData, Phase I drugs for Lupus Nephritis have an 84% phase transition success rate ...

An analysis of 2024 Google search data revealed the top health questions asked by Americans. A registered nurse provides ...

EMBL scientists uncover potential use of an FDA-approved over-the-counter cough syrup ingredient to treat fibrotic lung ...

Now, scientists at Stanford University have found that a faulty genetic molecule could be responsible for the immune system misidentifying healthy tissue as a threat. The breakthrough study, published ...

If reading about these atrocities churns your stomach, reflect on what is going on before our eyes these very days ...

In a new study published in Lupus Science & Medicine, researchers explored the efficacy of using a combination of belimumab and standard immunotherapy compared to standard immunotherapy alone in ...